Overview
Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others.
Dr. Atta is rated as an Advanced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.
His clinical research consists of co-authoring 94 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Systemic Lupus Erythematosus (SLE).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 7, Floor 7, Baltimore, MD 21287
1717 East Monument Street, Park Building, Ground Level, Baltimore, MD 21287
301 Mason Lord Drive, Suite 3400, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Chandra Mohan is a Nephrologist in York, Pennsylvania. Dr. Mohan is rated as a Distinguished provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Systemic Lupus Erythematosus (SLE), Goodpasture Syndrome, and Tissue Biopsy.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Derek M. Fine is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include glomerular kidney disease, particularly lupus nephritis and other immune-mediated kidney diseases, HIV-related kidney disease, scleroderma-related kidney disease, acute kidney injury, hyponatremia, kidney biopsy, and rhabdomyolysis. Dr. Fine earned his M.D. at Johns Hopkins. He completed his residency in internal medicine and his fellowship in nephrology at Johns Hopkins. His research interests include HIV-related kidney diseases and lupus nephritis. He is a member of the Miller Coulson Academy of Clinical Excellence and was named 2018 Physician of the Year at Johns Hopkins Hospital. Dr. Fine is rated as a Distinguished provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Systemic Lupus Erythematosus (SLE), Chronic Kidney Disease, and Kidney Transplant.
Johns Hopkins University
Jose Monroy-Trujillo is a Nephrologist in Baltimore, Maryland. Dr. Monroy-Trujillo is rated as a Distinguished provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Chronic Kidney Disease, and Systemic Lupus Erythematosus (SLE). Dr. Monroy-Trujillo is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Kidney DiseaseDr. Atta isDistinguished. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)Dr. Atta isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- GlomerulonephritisDr. Atta isDistinguished. Learn about Glomerulonephritis.
- Lupus NephritisDr. Atta isDistinguished. Learn about Lupus Nephritis.
- Advanced
- Acute Kidney FailureDr. Atta isAdvanced. Learn about Acute Kidney Failure.
- Fabry DiseaseDr. Atta isAdvanced. Learn about Fabry Disease.
- Focal Segmental Glomerulosclerosis
- Interstitial NephritisDr. Atta isAdvanced. Learn about Interstitial Nephritis.
- Kidney TransplantDr. Atta isAdvanced. Learn about Kidney Transplant.
- NephrosclerosisDr. Atta isAdvanced. Learn about Nephrosclerosis.
- Experienced
- Autosomal Dominant Polycystic Kidney Disease
- CalcinosisDr. Atta isExperienced. Learn about Calcinosis.
- Childhood Hypophosphatasia (HPP)Dr. Atta isExperienced. Learn about Childhood Hypophosphatasia (HPP).
- Congenital Nephrotic SyndromeDr. Atta isExperienced. Learn about Congenital Nephrotic Syndrome.
- Diabetic NephropathyDr. Atta isExperienced. Learn about Diabetic Nephropathy.
- Feingold SyndromeDr. Atta isExperienced. Learn about Feingold Syndrome.